Sign in

CIK 0001053691

  • Non-accelerated filer
  • Smaller reporting company

CervoMed Inc.

Sign in to watch
Ticker
CRVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
300645032
Phone
+1 617-744-4400
Business address
20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
Former names
Diffusion Pharmaceuticals Inc., RestorGenex Corp, Stratus Media Group, Inc, FERIS INTERNATIONAL, INC., TITAN MOTORCYCLE CO OF AMERICA INC
  1. 4 Open-market buy Chief Commercial and Business bought 5,000 shares at an average $8.29 ($41,430)
  2. 4 Open-market buy Director bought 21,600 shares at $8.46 ($182,736)
  3. 4 Open-market buy CFO, GC & Secretary bought 3,500 shares at an average $8.36 ($29,250)
  4. 4 Open-market buy CEO & President bought 21,600 shares at $8.46 ($182,736)
  5. 4 Open-market buy Director bought 7,847 shares at an average $7.53 ($59,101)
  6. 4 Open-market buy CEO & President bought 7,847 shares at an average $7.53 ($59,101)
  7. 4 Open-market buy Chief Commercial and Business bought 10,000 shares at $7.57 ($75,700)
  8. 4 Open-market buy Director bought 5,553 shares at $7.35 ($40,815)
  9. 4 Open-market buy CFO, GC & Secretary bought 3,500 shares at $7.44 ($26,040)
  10. 4 Open-market buy CEO & President bought 5,553 shares at $7.35 ($40,815)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 2 of 13 · 256 filings